Court: Innovators can be liable for generic injuries
This article was originally published in Scrip
Executive Summary
In a 15 August decision similar to one it issued last year, the Alabama Supreme Court said brand-name drug makers like Pfizer can be held liable for a lack of warnings on generic forms of their medicines – a ruling that could have implications in other lawsuits.